SALT LAKE CITY, UT--(MARKET WIRE)--Aug 9, 2006 -- BioMicro® Systems, Inc. announced today that, effective immediately, Michael Feldman, Ph.D., has been appointed Chief Executive Officer of the company. Michael will be focused on improving operations and growing the sales of the MAUI® Hybridization System and associated products by addressing growth markets in life science discovery and diagnostics in the US, Europe and Asia. Board director Greg Warnock said, “BioMicro has experienced exceptional growth and is pleased to have attracted a senior manager with a proven track record as CEO. Michael has the qualifications and drive to take the company to the next level.”
Michael Feldman, Ph.D., Chief Executive Officer of BioMicro Systems, has held high-level positions with a number of well-known healthcare companies. As General Manager at Northwest Toxicology, Dr. Feldman restructured a division, which ultimately led to it being acquired by LabOne, Inc. At LabOne, Dr. Feldman served as Vice President of Business Development and was instrumental in providing strategic leadership for the employment services division of a $450M clinical laboratory. He also led programs to grow the market for esoteric drug testing as well as developed strategic and tactical plans and marketing/branding initiatives. “Michael is a leader who accomplishes objectives through execution, collaboration, and customer input,” adds Stephen Blose, VMD, Ph.D., Board director.
About BioMicro Systems
BioMicro Systems, Inc., founded in 2000 and based in Salt Lake City, Utah, is a private company focused on the development and commercialization of biological research products based on its proprietary microfluid and microarray technologies. In 2003 BioMicro Systems launched the MAUI Hybridization System, a cutting-edge microarray hybridization instrument, designed to alleviate the processing bottleneck encountered during the microarray hybridization process and to help researchers achieve greater sensitivity and more consistent/reproducible results. To date, over 275 MAUI Systems have been sold worldwide. BioMicro Systems strives to become the company to provide the standard for achieving superb microarray hybridization results. More company information can be found at www.biomicro.com.
Contact: For MAUI System specifications, product demos, and sales information in the United States and other countries, please contact:
BioMicro Systems, Inc. Phone: 801-303-1470 E-mail: Email Contact
Source: BioMicro Systems, Inc.
